Submit Your Information

If you suffered a loss on your Stevanato Group S.p.A. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Are you a current or former employee of the company?*

YesNo

Purchases
Sales

Purchases

+Additional Purchases

Sales

+Additional Sales

On November 3, 2026, Stevanato reported third quarter 2026 results, including, among other things, that GLP-1 revenue fell to roughly 17–18% of total company revenue, and the Company now expects low single-digit growth in 2027 amid lower GLP-1 syringe volumes “tied to one customer.”

On this news, Stevanato shares fell $5.64 or 28.57%, to close at $14.10 on November 3, 2026, thereby injuring investors.

Submit Your Information